Generics Bulletin is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Glenmark Invites Investment Into Its Independent APIs Unit

Executive Summary

Bringing in a minority investor for its Glenmark Life Sciences raw materials unit and divesting non-core products are among the strategic priorities for Glenmark in its current financial year ending in March 2020.


Related Content

Glenmark Ponders Partners For Omalizumab And Ryaltris Spray
People Round-Up: Glenmark Recruits API Head From Mylan
Novitium’s Pyridostigmine Shows Six Appeal Of CGT Pathway


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts